News & Updates

A school-based personality-focused intervention shows potential in lowering the rates of substance use disorder (SUD) among adolescents, reports a study.

A study using data from the CARTaGENE cohort links lower estimated glomerular filtration rate (eGFR) to cognitive impairment and brain alterations.

In the treatment of moderate-to-severe papulopustular rosacea (PPR), the low-dose modified formulation of minocycline hydrochloride, DFD-29, appears to have superior efficacy compared with both doxycycline and placebo, according to data from the phase III MVOR-1 and MVOR-2 studies.

The addition of a single subcutaneous dose of zilebesiran to background therapies appears to provide blood pressure (BP)-lowering benefit in patients with uncontrolled hypertension, according to the phase II KARDIA-2 study.

Positive drain tip cultures (DTC) do not have a significant association with the occurrence of surgical site infection (SSI) following paediatric cardiovascular surgery, according to a study.

For patients with chronic kidney disease (CKD) who are facing social isolation, survival is shortened while the onset of cardiovascular disease is accelerated, as shown in a prospective cohort study.

Cytisinicline’s efficacy and tolerability for smoking cessation has been validated in another large phase III trial conducted in the US, with both the 6- and 12-week treatments yielding positive benefits persisting through 24 weeks.

Substantial changes in remnant cholesterol levels over time are associated with a heightened risk of stroke in the general population, according to a study.

In the first-line treatment of patients with adult-onset Still’s disease (AOSD), biological disease-modifying antirheumatic drug (DMARD) therapy is associated with increased likelihood of achieving sustained, event-free remission in addition to fewer complications compared with conventional synthetic (cs) DMARDs, according to a study from Germany.